NOTICE
ANSM - Updated: 24/06/2014
Name of the drug
CORYZALIA, orodispersible tablet
framed
Read this leaflet carefully before taking this medicine. It contains important information for your treatment.
If you have further questions, if you are not sure, ask your doctor or pharmacist for more information.
· Keep this leaflet, you may need to read it again.
· If you need more information and advice, talk to your pharmacist.
· If symptoms worsen or persist after one week, seek medical attention.
· If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Summary notice
In this notice :
1. What is CORYZALIA, orodispersible tablet and in which cases is it used?
2. What information do you need to know before taking CORYZALIA, orodispersible tablet ?
3. How to take CORYZALIA, orodispersible tablet ?
4. What are the possible side effects?
5. How to store CORYZALIA, orodispersible tablet ?
6. Additional information.
1. WHAT IS CORYZALIA, orodispersible tablet AND WHAT IT IS USED FOR?
Pharmacotherapeutic class
Not applicable.
Therapeutic indications
CORYZALIA, orodispersible tablet is a homeopathic medicine traditionally used in the symptomatic treatment of colds and rhinitis.
2. BEFORE YOU TAKE CORYZALIA, orodispersible tablet?
List of information needed before taking the medication
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Cons-indications
Never use CORYZALIA, orodispersible tablet:
· In children under 18 months.
· If you are allergic (hypersensitive) to the active substances or to any of the ingredients in CORYZALIA, orodispersible tablets.
Precautions for use; special warnings
Take care with CORYZALIA, orodispersible tablet:
· The use of this drug is not recommended in patients with galactose intolerance, Lapp lactase deficiency or glucose or galactose malabsorption syndrome (rare hereditary diseases).
Interactions with other drugs
Taking other medicines:
If you are taking or have recently taken any other medicines, including medicines obtained without a prescription, tell your doctor or pharmacist.
Interactions with food and drinks
Food and drinks
This medicine is to be taken away from meals.
Interactions with herbal products or alternative therapies
Not applicable.
Use during pregnancy and lactation
Pregnancy and breast feeding
Ask your doctor or pharmacist for advice before taking any medicine.
Sport
Not applicable.
Effects on ability to drive or use machines
Driving and using machines
Not applicable.
List of excipients with known effect
Important information about some of the ingredients of CORYZALIA, orodispersible tablet :
This medicine contains lactose.
3. HOW TO TAKE CORYZALIA, orodispersible tablet?
Instructions for a good use
Not applicable.
Dosage, Mode and / or Route (s) of Administration, Frequency of Administration and Duration of Treatment
Dosage
Reserved for adults and children over 18 months.
Adults and children from 18 months: 1 tablet 6 to 8 times a day.
Administration in children from 18 months to 6 years requires dissolving the tablet in a little water.
Method and route of administration
Sublingual route.
Frequency of administration
Space the catches as soon as possible and stop the catches as soon as the symptoms disappear.
Duration of treatment
The duration of treatment should not exceed one week.
Symptoms and instructions in case of overdose
If you take more CORYZALIA, orodispersible tablet than you should:
Consult your doctor or your pharmacist.
Instructions for omitting one or more doses
If you forget to take CORYZALIA, orodispersible tablet:
Do not take a double dose to make up for the dose you forgot to take.
Risk of withdrawal syndrome
Not applicable.
4. WHAT ARE THE POSSIBLE SIDE EFFECTS?
Description of adverse effects
Like all medicines, CORYZALIA, orodispersible tablet can have side effects, although not everybody gets them.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
5. HOW TO STORE CORYZALIA, orodispersible tablet?
Keep out of the reach and sight of children.
Expiration date
Do not use CORYZALIA, orodispersible tablet after the expiry date stated on the carton.
Storage conditions
Store at a temperature not exceeding 30 ° C.
If necessary, warn against some visible signs of deterioration
Medicines should not be thrown away with sewage or garbage. Ask your pharmacist what to do with unused medications. These measures will help protect the environment.
6. ADDITIONAL INFORMATION
Complete list of active substances and excipients
What does CORYZALIA, orodispersible tablet contain?
The active substances are :
ALLIUM CEPA 3CH ............................................... .................................................. ........................ 0.5 mg
BELLADONNA 3CH ................................................ .................................................. 0.5 mg
KALIUM BICHROMICUM 3CH ............................................... .................................................. 0.5 mg
GELSEMIUM 3CH ................................................ .................................................. ........................... 0.5 mg
SABADILLA 3CH ................................................ .................................................. ............................. 0.5 mg
for a 250 mg orodispersible tablet.
The other components are :
Lactose, croscarmellose sodium, magnesium stearate.
Pharmaceutical form and content
What is CORYZALIA, orodispersible tablet and contents of the pack?
CORYZALIA, orodispersible tablet is in the form of orodispersible tablets. They are packaged in a box containing 40 tablets.
Name and address of the marketing authorization holder and the production authorization holder responsible for batch release, if different
Holder
Boiron
2 AVENUE OF WESTERN LYONNAIS
69510 MESSIMY
exploiting
Boiron
2 AVENUE OF WESTERN LYONNAIS
69510 MESSIMY
Maker
Boiron
2 avenue west Lyon
69510 messimy
LA FRANCE
Names of the drug in the member states of the European Economic Area
Not applicable.
Date of approval of the notice
The last date this notice was approved is {date}.
AMM under exceptional circumstances
Not applicable.
Internet information
Detailed information on this medicine is available on the ANSM website (France).
Information reserved for health professionals
Not applicable.
Other
Not applicable.